PPAR Agonists and Cardiovascular Disease in Diabetes

<table>Gene expression of the angiotensin II subtype
1 receptor as assessed by real-time RT-PCR in aorta from apoE knockout mice
treated with the PPAR<i>γ</i> agonist, rosiglitazone
or the PPAR<i>α</i> agonist, gemfibrozil for 20 weeks. <i>P</i> &lt; .05 versus diabetic mice.</table>

PPAR Research

fig4

Figure 4

Figure 4: PPAR Agonists and Cardiovascular Disease in Diabetes 